Therapy of Bleeding Disorders as Support The BPC 157 therapy of the bleeding disorders can be considered as an implementation and support of its wound healing effect (Seiwerth et al., 1997
It can increase heart rate, so individuals with pre-existing heart conditions should be closely monitored when utilising this peptide in clinical research
The spray format ships pre-formulated, removing the reconstitution step required for lyophilized vials
These documents are reviewed internally and displayed as they become available
Google sees this as a coherent topical group, not isolated pages
The Science Behind Regeno Blend (BPC-157, TB-500, Cartalax) 30mg Product Name: REGENO Cartalax + TB-500 + BPC-157 Strength: 30mg Total Peptide Content Blend Composition: Cartalax 10mg TB-500 10mg BPC-157 10mg Chemical Name: Multi-Peptide Research Blend (Cartalax + TB-500 + BPC-157) Appearance: White to Off-White Lyophilized Powder Classification: Multi-Peptide Research Compound Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS)